UBS Group
SSKN

UBS Group’s Strata Skin Sciences SSKN Stock Holding History

UBS Group’s Portfolio SSKN Stock Details SSKN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,061
Closed -$1.34K – 11136
2025
Q4 		$1.34K Buy
1,061
+691
+187% +$1.09K ﹤0.01% 9621
2025
Q3 		$762 Sell
370
-6,940
-95% -$13.8K ﹤0.01% 9547
2025
Q2 		$16.7K Sell
7,310
-3,644
-33% -$9.11K ﹤0.01% 8555
2025
Q1 		$28.9K Sell
10,954
-2,451
-18% -$6.83K ﹤0.01% 7970
2024
Q4 		$39K Buy
13,405
+4,157
+45% +$12.4K ﹤0.01% 7457
2024
Q3 		$25.4K Buy
9,248
+7,778
+529% +$24.3K ﹤0.01% 7230
2024
Q2 		$4.51K Sell
1,470
-168
-10% -$681 ﹤0.01% 8081
2024
Q1 		$6.19K Buy
+1,638
New +$8.55K ﹤0.01% 7478
2023
Q4 		– Sell
-6
Closed -$37 – 9854
2023
Q3 		$37 Sell
6
-792
-99% -$6.09K ﹤0.01% 9052
2023
Q2 		$7.58K Sell
798
-95
-11% -$935 ﹤0.01% 7280
2023
Q1 		$9.46K Buy
893
+95
+12% +$955 ﹤0.01% 7654
2022
Q4 		$6.3K Hold
798
– – ﹤0.01% 9051
2022
Q3 		$7K Sell
798
-403
-34% -$4.09K ﹤0.01% 8903
2022
Q2 		$12K Buy
1,201
+791
+193% +$9.39K ﹤0.01% 7680
2022
Q1 		$6K Buy
410
+194
+90% +$2.9K ﹤0.01% 8996
2021
Q4 		$3K Sell
216
-476
-69% -$7.9K ﹤0.01% 9691
2021
Q3 		$13K Buy
692
+223
+48% +$3.4K ﹤0.01% 7685
2021
Q2 		$7K Buy
469
+468
+46,800% +$7.28K ﹤0.01% 8353
2021
Q1 		$0 Hold
1
– – ﹤0.01% 9437
2020
Q4 		$0 Sell
1
-1
-50% -$14 ﹤0.01% 8734
2020
Q3 		$0 Sell
2
-39
-95% -$539 ﹤0.01% 8386
2020
Q2 		$0 Buy
41
+40
+4,000% +$474 ﹤0.01% 8336
2020
Q1 		$0 Sell
1
-426
-100% -$7.03K ﹤0.01% 8377
2019
Q4 		$9K Buy
427
+302
+242% +$6.86K ﹤0.01% 7349
2019
Q3 		$3K Sell
125
-85
-40% -$1.99K ﹤0.01% 7657
2019
Q2 		$5K Sell
210
-19
-8% -$474 ﹤0.01% 7390
2019
Q1 		$7K Buy
229
+228
+22,800% +$6.94K ﹤0.01% 7019
2018
Q4 		$0 Sell
1
-164
-99% -$4.69K ﹤0.01% 8276
2018
Q3 		$6K Sell
165
-540
-77% -$13.3K ﹤0.01% 7415
2018
Q2 		$14K Buy
705
+470
+200% +$7.67K ﹤0.01% 6949
2018
Q1 		$3K Sell
235
-166
-41% -$2.21K ﹤0.01% 7442
2017
Q4 		$5K Buy
401
+337
+527% +$4.71K ﹤0.01% 7393
2017
Q3 		$1K Buy
64
+42
+191% +$774 ﹤0.01% 7590
2017
Q2 		$1K Sell
22
-28
-56% -$780 ﹤0.01% 7517
2017
Q1 		$1K Buy
50
+33
+194% +$937 ﹤0.01% 7461
2016
Q4 		$0 Sell
17
-259
-94% -$6.62K ﹤0.01% 8023
2016
Q3 		$7K Buy
276
+210
+318% +$6.68K ﹤0.01% 6996
2016
Q2 		$2K Sell
66
-166
-72% -$6.68K ﹤0.01% 7448
2016
Q1 		$11K Sell
232
-29
-11% -$1.5K ﹤0.01% 6606
2015
Q4 		$15K Sell
261
-373
-59% -$21.3K ﹤0.01% 7014
2015
Q3 		$36K Sell
634
-13
-2% -$753 ﹤0.01% 6112
2015
Q2 		$37K Buy
647
+177
+38% +$14.4K ﹤0.01% 6284
2015
Q1 		$60K Buy
470
+435
+1,243% +$43K ﹤0.01% 5878
2014
Q4 		$2K Buy
+35
New +$2.87K ﹤0.01% 9423

UBS Group's SSKN Position: Q1 2026 in Review

UBS Group sold out of Strata Skin Sciences (SSKN) in Q1 2026, closing a stake of 1,061 shares — an estimated $1.34K sold.

UBS Group first reported a position in SSKN in Q4 2014 and held it in 44 quarters. The position peaked at $60K in Q1 2015. 0 funds tracked by Wall St. Rank hold SSKN as of Q1 2026.

  • UBS Group reported no remaining Strata Skin Sciences position as of Q1 2026 after selling out during the quarter.
  • UBS Group sold 1,061 Strata Skin Sciences shares in Q1 2026, an estimated $1.34K.
  • UBS Group first reported a position in Strata Skin Sciences in Q4 2014 and held it in 44 quarters.
  • UBS Group's Strata Skin Sciences position peaked at $60K in Q1 2015.
  • 0 funds tracked by Wall St. Rank held Strata Skin Sciences as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.